Skyline Ventures

Skyline Ventures

Skyline Ventures is a venture capital firm that specialises in investing in outstanding product-focused healthcare companies.

Skyline Ventures is a venture capital firm that specialises in investing in outstanding product-focused healthcare companies with expertise include small molecule and protein therapeutics; medical devices; diagnostics; and technologies that facilitate drug discovery and life science research. The company was founded in 1997 by a group of medical professionals led by John Freund and Eric M. Gordon. Its headquarters is located in Palo Alto, California.

Skyline Ventures has approximately $800 million under management. It targets to invest $15-35 million per portfolio company over the life of the company. Among the companies included in Skyline Ventures' portfolio are AcelRx Pharmaceuticals, Avidia, Crescendo Bioscience, and NovaCardia.

Timeline

People

Name
Role
LinkedIn

David Chan

Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.